Cervical Cancer Screening

Cervical Cancer Screening - most related articles:

- Regular pap tests boost chances of cure from cervical cancer - 9.3
- Early cervical cancer screening may harm women - 9.2
- Cervical cancer screening to 50000 women in India - 8.8
- HPV DNA testing for all women aged 29 years and above - 8.3
- Persistent HPV infection raises cervical cancer risk - 7.9
- TV ad to educate women about cervical cancer and HPV test - 7.8
- Cervical cancer screening should be less frequent - 7.5
- Breast cancer and cervical cancer rising in developing countries - 7.2
- Cervical cancer screening might safely be delayed after HPV vaccine - 7.1
- Gardasil vaccine to prevent cervical cancer in India - 6.8

Cervical Cancer Screening articles

Regular pap tests boost chances of cure from cervical cancer
Women who undergo Pap tests have higher survival rates of cervical cancer. Women can boost their chances of surviving cervical cancer substantially through regular cervical screening, claims a research paper published in BMJ.

HPV DNA testing for all women aged 29 years and above
Implementation of HPV DNA testing in cervical screening leads to earlier detection of clinically relevant CIN grade 2 or worse, which when adequately treated, improves protection against CIN grade 3 or worse and cervical cancer. Early detection of high-grade cervical legions caused by HPV16 was a major component of this benefit.

Breast cancer and cervical cancer rising in developing countries
The number of cases and deaths from breast and cervical cancer are rising in most countries, especially in the developing world where more women are dying at younger ages, according to a new global analysis by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

Screening for cervical cancer too frequently
Many physicians reported overscreening women by using both the HPV and Pap tests annually. Clinical guidelines recommend screening low-risk women for cervical cancer every three years after age 30.

Cervical cancer screening should be less frequent
Women should have their first cervical cancer screening at age 21 and can be rescreened less frequently than previously recommended, reported by US researchers at ACOG.

African American women get delay in breast cancer related care
African-American women face obstacles to receive appropriate breast cancer–related care in US. There is a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality.

Early cervical cancer screening may harm women
UK's Advisory Committee on Cervical Screening (ACCS) has agreed unanimously for no change in the screening age as evidence showed that earlier screening could do more harm than good causing too many false positives and increase the risk of premature births in some women.

Cervical cancer screening to 50000 women in India
QIAGEN and the Chittaranjan National Cancer Institute (CNCI) announced a collaboration to establish the first large-scale cervical cancer screening program for women in Kolkata, India.

Cervical cancer screening might safely be delayed after HPV vaccine
DNA from human papilloma virus type 16 (HPV16) and HPV type 18 (HPV18) were found in the majority of invasive cervical cancers in New Mexico in the 1980s and 1990s, according to a population-based study published in the March 24 online issue of the Journal of the National Cancer Institute.

TV ad to educate women about cervical cancer and HPV test
Through a new advertising campaign being launched in US, local women will soon learn more about cervical cancer screening and prevention.

Gardasil approval delayed for use in women ages 27 - 45
Merck & Co., Inc. announced that the U.S. Food and Drug Administration has issued a second complete response letter regarding the supplemental biologics license application (sBLA) for the use of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] in women ages 27 though 45.

HPV vaccine Cervarix in UK's immunisation programme
The UK's leading cervical cancer charity, Jo's Trust, has welcomed the UK's Department of Health's announcement that the HPV vaccine, Cervarix will be used in the national immunisation programme for 12/13 year olds starting in September, 2008.

Persistent HPV infection raises cervical cancer risk
Persistent infection with human papillomavirus (HPV) could be a useful clinical marker for increased risk of cervical cancer, the second most common cancer in women worldwide, revealed by researchers from the University of North Carolina at Chapel Hill.

13 Cervical Cancer Screening articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.39